Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Bournez

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecular Informatics|June 12, 2024
Virtual screening of natural products to enhance melanogenosisColin Bournez, José-Manuel Gally, Samia Aci-Sèche, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Frags2Drugs: A Novel In Silico Fragment-Based Approach to the Discovery of Kinase InhibitorsGautier Peyrat, Colin Bournez, Pascal Krezel, et al.
Molecules (Basel, Switzerland)|July 19, 2020
Comparative Assessment of Protein Kinase Inhibitors in Public Databases and in PKIDBColin Bournez, Fabrice Carles, Gautier Peyrat, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 19, 2023
Diversification of Simple Arenes into Complex (Amino)cyclitolsElisa Angelini, Matteo Martinelli, Eugenio Roà, et al.
Journal of Chemical Information and Modeling|March 23, 2023
Transformer Performance for Chemical Reactions: Analysis of Different Predictive and Evaluation ScenariosFernando Jaume-Santero, Alban Bornet, Alain Valery, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
CalcAMP: A New Machine Learning Model for the Accurate Prediction of Antimicrobial Activity of PeptidesColin Bournez, Martijn Riool, Leonie de Boer, et al.
Antibiotics (Basel, Switzerland)|November 27, 2025
Machine Learning-Identified Potent Antimicrobial Peptides Against Multidrug-Resistant Bacteria and Skin InfectionsGizem Babuççu, Nikitha Vavilthota, Colin Bournez, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretionWillemien van Zwol, Antoine Rimbert, Justina C Wolters, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecular Informatics|June 12, 2024
Virtual screening of natural products to enhance melanogenosisColin Bournez, José-Manuel Gally, Samia Aci-Sèche, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Frags2Drugs: A Novel In Silico Fragment-Based Approach to the Discovery of Kinase InhibitorsGautier Peyrat, Colin Bournez, Pascal Krezel, et al.
Molecules (Basel, Switzerland)|July 19, 2020
Comparative Assessment of Protein Kinase Inhibitors in Public Databases and in PKIDBColin Bournez, Fabrice Carles, Gautier Peyrat, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 19, 2023
Diversification of Simple Arenes into Complex (Amino)cyclitolsElisa Angelini, Matteo Martinelli, Eugenio Roà, et al.
Journal of Chemical Information and Modeling|March 23, 2023
Transformer Performance for Chemical Reactions: Analysis of Different Predictive and Evaluation ScenariosFernando Jaume-Santero, Alban Bornet, Alain Valery, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
CalcAMP: A New Machine Learning Model for the Accurate Prediction of Antimicrobial Activity of PeptidesColin Bournez, Martijn Riool, Leonie de Boer, et al.
Antibiotics (Basel, Switzerland)|November 27, 2025
Machine Learning-Identified Potent Antimicrobial Peptides Against Multidrug-Resistant Bacteria and Skin InfectionsGizem Babuççu, Nikitha Vavilthota, Colin Bournez, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretionWillemien van Zwol, Antoine Rimbert, Justina C Wolters, et al.
Pageof 1